Virginia Commonwealth University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).
Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.
Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
558 total, page 2 of 12
Cryospray Therapy for Benign Airway Stenosis
NCT06085209
Health Education Approach to Lung Screening
NCT06070870
Testing of Online Version of QAPS
NCT05905523
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
NCT05886582
The Impact of Chronic E-Cigarette Usage on Microvascular Health
NCT06860698
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
NCT05720663
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
NCT05805722
Impact of 4PCP on Practitioner and Patient Outcomes
NCT05580419
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
NCT05618054
Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy
NCT05259527
Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
NCT05548452
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
NCT05224778
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
NCT05194111
Transspinal Stimulation With and Without Blood Flow Restricted Exercise Via Telehealth in Persons With Tetraplegia
NCT05423600
Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
NCT05177822
Preventing Firearm Violence in Youth: A Hospital-based Prevention Strategy
NCT05078164
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3
NCT04916340
Cardiovascular Health & Early Stress
NCT06557707
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2
NCT04922762
Mindful Moms Randomized Control Trial
NCT04886856
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
NCT04916327
Preventing Retaliatory Gun Violence in Violently Injured Adults
NCT04813185
CIMR Neuromuscular Research Biobank
NCT05434572
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
NCT05334732
Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer
NCT04643366
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
NCT03919292
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
NCT03981575
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients
NCT06001320
Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes
NCT05639088
Defining Endpoints in Becker Muscular Dystrophy
NCT05257473
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer
NCT04502602
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
NCT02957968
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
NCT02515110
A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler
NCT07013396
Single FrAction Interstitial BreaSt BracHytherApy
NCT07654257
Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy
NCT07639086
TENS of Auricular Vagal Nerve for Radiation Necrosis
NCT07680127
Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
NCT05936931
Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers
NCT07531316
Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma
NCT07365839
Virtual Housecalls: Redesigning Pediatric Primary Care Adolescent Obesity Treatment
NCT07246603
Enhancing Addiction Treatment Through Psychoeducation
NCT07178158
Using Apollo Neuro in Autistic Children With Self-Injurious Behavior
NCT07648420
The Impact of Improved Vagal Function on Periaqueductal Gray Connectivity
NCT05618067
Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry
NCT05974644
Enhancing an Existing Prevention Strategy to Reduce Intentional Firearm Injuries Among High-risk Youth (Phase 1)
NCT07305467
Sleep Extension to Improve Sleep Efficiency and QoL in HF With Preserved Ejection Fraction: the SLEEP-HF Pilot Study
NCT06567925
CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
NCT06439420
Resin Polymer (NuSmile BioFlx) Compared to Stainless Steel Crowns (3M ESPE) for Restoration of Primary Molar Teeth
NCT06354634
Zirconia-based Primary Anterior Crowns With Retention Grooves Versus Without Retention Grooves
NCT06354647
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 65 |
| Phase 3 | 13 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the Virginia Commonwealth University pipeline
77 recruiting of 558 indexed (14% open); 380 completed (68%).
Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Virginia Commonwealth University: open-pipeline peers nationwide
Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 558 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Ohio State University · 552 trials · 21% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Lindenwood University · 14% recruiting · 29 trials
- BeiGene · 14% recruiting · 65 trials
- Reproductive Medicine Associates of New Jersey · 14% recruiting · 51 trials
- University of Cincinnati · 14% recruiting · 245 trials
Related
What to do with this Virginia Commonwealth University page
558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.
- 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets.Report a data error.